Harrow HROW
NASDAQ HROW
$37.80 -0.05 (-0.13%)
As of: Sep 9, 2026 · 1:48 PM EDT

Harrow (HROW) Tax Provisions (2017 - 2026)

Harrow (HROW) posted Tax Provisions of $25000.0 for Q1 2026, up 104.86% on a QoQ basis from -$514000.0 in Q4 2024.

Analysis

Harrow (HROW) Tax Provisions (2017 - 2026) Analysis & Trends

Harrow has reported Tax Provisions for 5 years, with the latest figure at $25000.0 in Q1 2026.

  • On a quarterly basis, Tax Provisions changed N/A year-over-year to $25000.0 in Q1 2026; TTM through Jun 2026 was -$489000.0, a 403.73% decrease from a year earlier, with the FY2025 full-year figure at $3.8 million, up 2242.24% from the prior year.
  • Tax Provisions was $25000.0 for Q1 2026 at Harrow, up from -$514000.0 in the prior quarter.
  • The five-year high for Tax Provisions was $1.5 million in Q3 2023, with the low at -$535000.0 in Q4 2023.
  • Average Tax Provisions over 4 years is $96200.0, with a median of $22500.0 recorded in 2024.
  • The sharpest annual moves came in 2023 and 2024: Tax Provisions plunged 137.5% in 2023, then jumped 4466.67% in 2024.
  • Over 4 years, Tax Provisions stood at $35000.0 in 2022, then tumbled by 1628.57% to -$535000.0 in 2023, then rose by 3.93% to -$514000.0 in 2024, then jumped by 104.86% to $25000.0 in 2026.
  • The last three Tax Provisions figures came in at $25000.0 (Q1 2026), -$514000.0 (Q4 2024), and $20000.0 (Q3 2024), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Taxes (Qtr)
1 Johnson & Johnson 645.47 Bn 624.71 Bn 17.26 Bn 1.21 Bn
2 AbbVie 439.99 Bn 433.42 Bn 12.70 Bn 662.00 Mn
3 Merck 365.45 Bn 358.31 Bn 12.21 Bn 654.00 Mn
4 Novartis Ag 266.57 Bn 258.88 Bn 11.24 Bn -1.01 Bn
5 Pfizer 159.03 Bn 147.33 Bn 10.94 Bn -407.00 Mn
6 Sanofi 52.43 Bn 45.05 Bn 10.79 Bn -524.23 Mn
7 Revolution Medicines 44.23 Bn 44.23 Bn - -
8 Incyte 25.32 Bn 20.79 Bn 1.57 Bn 165.91 Mn
9 United Therapeutics 21.44 Bn 18.77 Bn 683.80 Mn 39.70 Mn
10 Harrow 1.42 Bn 1.33 Bn 50.36 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 25,000.00
Dec 31, 2024 -514,000.00
Sep 30, 2024 20,000.00
Jun 30, 2024 655,000.00
Dec 31, 2023 -535,000.00
Sep 30, 2023 1.54 Mn
Jun 30, 2023 -15,000.00
Mar 31, 2023 -288,000.00
Sep 30, 2022 35,000.00
Jun 30, 2022 40,000.00
Dec 31, 2017 -851,000.00
Sep 30, 2017 -28,000.00
Jun 30, 2017 -28,000.00
Mar 31, 2017 -28,000.00